multiple sclerosis

Merck KGaA Drug Fails to Convince FDA
WSJ Online
Wed, 03/2/11 - 11:56 am
Merck KGaA
FDA
cladribine
MS
multiple sclerosis
Questcor Has a Drug Problem
WSJ
Sun, 02/13/11 - 10:56 am
Questcor Pharmaceuticals
Athcar
multiple sclerosis
infantile spasms
Teva Risks Disappointments as Top Drug Faces Threats
Bloomberg
Wed, 02/9/11 - 11:50 am
Teva Pharmaceuticals
Copaxone
generics
MS
multiple sclerosis
First MS pill may be available soon (in the UK)
Press Assocation News
Sat, 01/22/11 - 10:18 am
multiple sclerosis
Gilenya
Novartis
Acorda, Biogen fall on EU drug rejection
Marketwatch
Fri, 01/21/11 - 10:13 am
Acorda Therapeutics
Europe
Biogen Idec
Fampyra
MS
multiple sclerosis
Novartis MS Pill Wins European Backing as Rival Acorda Rejected
Bloomberg
Fri, 01/21/11 - 10:11 am
Novartis
MS
multiple sclerosis
Europe
Acorda Therapeutics
Gilenya
Merck KGaA
Biotech Firms Fight Generics
WSJ Online
Thu, 01/13/11 - 01:14 pm
generics
biotech
Amgen
Pfizer
Enbrel
Epogen
anemia
Biogen Idec
MS
Avonex
multiple sclerosis
arthritis
Biogen expects MS sales hit from Gilenya
Fierce Pharma
Wed, 01/12/11 - 07:17 pm
Biogen Idec
Gilenya
MS
multiple sclerosis
Sanofi Is Discussing Lemtrada Payments With Genzyme
Bloomberg
Mon, 01/10/11 - 12:38 pm
Sanofi
Lemtrada
Genzyme
MS
multiple sclerosis
Opexa soars on talks with FDA over MS drug
Marketwatch
Wed, 01/5/11 - 11:10 am
FDA
MS
Opexa
multiple sclerosis
Tovaxin
Biogen Idec begins selling Tysabri in India
Bizjournals.com
Tue, 12/28/10 - 01:11 pm
Indian
Tysabri
Biogen Idec
MS
multiple sclerosis
Teva Pharma Rises on Optimism of Reduced Competition for Copaxone MS Drug
Bloomberg
Mon, 12/27/10 - 08:24 am
Teva Pharmaceuticals
Copaxone
multiple sclerosis
MS
FDA
Teva May Face Copaxone Copy From Novartis, Momenta as Soon as Next Month
Bloomberg
Thu, 12/23/10 - 08:38 am
Teva Pharmaceuticals
Novartis
Copaxone
Momenta
generics
MS
multiple sclerosis
Biogen Idec, Elan seek to update Tysabri labeling
Marketwatch
Wed, 12/22/10 - 09:00 am
Elan
Biogen Idec
Tysabri
MS
multiple sclerosis
Novartis Pill for Untreatable Multiple Sclerosis Might Reap $5.4 Billion
Bloomberg
Tue, 12/21/10 - 10:48 am
Novartis
MS
multiple sclerosis
Gilenya
Trophos and MS-Repair partners present promising data on novel approach in multiple sclerosis at SfN meeting
Pharmabiz
Sun, 11/28/10 - 11:36 am
Trophos SA
MS-Repair
Olesoxime
multiple sclerosis
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Sat, 11/27/10 - 01:15 pm
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt
Termeer Touts Campath-Linked CVRs
InVivo
Sat, 11/27/10 - 12:59 pm
Henri Termeer
Campath
MS
Genzyme
multiple sclerosis
Sanofi
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Sat, 11/27/10 - 12:53 pm
Genzyme
alemtuzumab
Sanofi
MS
multiple sclerosis
Genzyme Considers a Way Around Campath Impasse
WSJ Online
Mon, 11/22/10 - 10:31 am
Campath
Genzyme
multiple sclerosis
MS

Pages